Shrestha P, Ghoreyshi Z, George J
Sci Rep. 2025; 15(1):7308.
PMID: 40025156
PMC: 11873109.
DOI: 10.1038/s41598-025-91396-z.
Abbas S, Shafik R, Soomro N, Heer R, Adhikari K
Front Oncol. 2025; 14():1509362.
PMID: 39839785
PMC: 11746116.
DOI: 10.3389/fonc.2024.1509362.
Carbunaru S, Neshatvar Y, Do H, Murray K, Ranganath R, Nayan M
JMIR Med Inform. 2024; 12:e63289.
PMID: 39671594
PMC: 11694706.
DOI: 10.2196/63289.
Ma X, Zhang Q, He L, Liu X, Xiao Y, Hu J
Front Oncol. 2024; 14:1487676.
PMID: 39575423
PMC: 11578829.
DOI: 10.3389/fonc.2024.1487676.
Pak S, Park S, Park J, Cho S, Lee Y, Ahn H
Investig Clin Urol. 2024; 65(3):202-216.
PMID: 38714511
PMC: 11076794.
DOI: 10.4111/icu.20230435.
Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer model combined with convolutional neural network-based image analysis.
Tak S, Han G, Leem S, Lee S, Paek K, Kim J
Front Bioeng Biotechnol. 2024; 11:1302983.
PMID: 38268938
PMC: 10806080.
DOI: 10.3389/fbioe.2023.1302983.
Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
Liu R, Wu S, Yu H, Zeng K, Liang Z, Li S
Heliyon. 2023; 9(11):e22458.
PMID: 38034691
PMC: 10687050.
DOI: 10.1016/j.heliyon.2023.e22458.
Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma.
Higgins H, Nakhla A, Lotfalla A, Khalil D, Doshi P, Thakkar V
Diagnostics (Basel). 2023; 13(22).
PMID: 37998619
PMC: 10670510.
DOI: 10.3390/diagnostics13223483.
Bladder Cancer and Artificial Intelligence: Emerging Applications.
Laurie M, Zhou S, Islam M, Shkolyar E, Xing L, Liao J
Urol Clin North Am. 2023; 51(1):63-75.
PMID: 37945103
PMC: 10697017.
DOI: 10.1016/j.ucl.2023.07.002.
Mathematical modeling of BCG-based bladder cancer treatment using socio-demographics.
Savchenko E, Rosenfeld A, Bunimovich-Mendrazitsky S
Sci Rep. 2023; 13(1):18754.
PMID: 37907551
PMC: 10618543.
DOI: 10.1038/s41598-023-45581-7.
Artificial Intelligence in Urooncology: What We Have and What We Expect.
Fron A, Semianiuk A, Lazuk U, Ptaszkowski K, Siennicka A, Leminski A
Cancers (Basel). 2023; 15(17).
PMID: 37686558
PMC: 10486651.
DOI: 10.3390/cancers15174282.
Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends.
Shalata A, Shehata M, van Bogaert E, Ali K, Alksas A, Mahmoud A
Cancers (Basel). 2022; 14(20).
PMID: 36291803
PMC: 9599984.
DOI: 10.3390/cancers14205019.
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After Resection.
Liu C, Yang H, Feng Y, Liu C, Rui F, Cao Y
J Clin Transl Hepatol. 2022; 10(4):600-607.
PMID: 36062279
PMC: 9396318.
DOI: 10.14218/JCTH.2021.00348.
Artificial intelligence and machine learning in precision and genomic medicine.
Quazi S
Med Oncol. 2022; 39(8):120.
PMID: 35704152
PMC: 9198206.
DOI: 10.1007/s12032-022-01711-1.
The Role of Artificial Intelligence in Early Cancer Diagnosis.
Hunter B, Hindocha S, Lee R
Cancers (Basel). 2022; 14(6).
PMID: 35326674
PMC: 8946688.
DOI: 10.3390/cancers14061524.
Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer.
Shishido S, Sayeed S, Courcoubetis G, Djaladat H, Miranda G, Pienta K
Cancers (Basel). 2022; 14(3).
PMID: 35159025
PMC: 8833768.
DOI: 10.3390/cancers14030758.
Applications of artificial intelligence in urological setting: a hopeful path to improved care.
Eun S, Kim J, Kim K
J Exerc Rehabil. 2021; 17(5):308-312.
PMID: 34805018
PMC: 8566099.
DOI: 10.12965/jer.2142596.298.
Artificial Intelligence Applications in Urology: Reporting Standards to Achieve Fluency for Urologists.
Chen A, Haque T, Roberts S, Rambhatla S, Cacciamani G, Dasgupta P
Urol Clin North Am. 2021; 49(1):65-117.
PMID: 34776055
PMC: 9147289.
DOI: 10.1016/j.ucl.2021.07.009.
Applied machine learning in cancer research: A systematic review for patient diagnosis, classification and prognosis.
Kourou K, Exarchos K, Papaloukas C, Sakaloglou P, Exarchos T, Fotiadis D
Comput Struct Biotechnol J. 2021; 19:5546-5555.
PMID: 34712399
PMC: 8523813.
DOI: 10.1016/j.csbj.2021.10.006.
Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility.
Mason J, Hasnain Z, Miranda G, Gill K, Djaladat H, Desai M
Eur Urol Open Sci. 2021; 32:8-18.
PMID: 34667954
PMC: 8505202.
DOI: 10.1016/j.euros.2021.07.006.